1. Assessment of the incorporation of patient-centric outcomes in studies of minimally invasive glaucoma surgical devices;Le;JAMA Ophthalmol,2016
2. Incorporating patients’ perspectives;Tarver;Glaucoma Today,2017
3. Patient preference information—voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling guidance for industry;Food and Drug Administration staff, and other stakeholders. 2016,2017
4. BEST (Biomarkers, EndpointS, and other Tools) resource,2016
5. Clinical Trials Dictionary: Terminology and Usage Recommendations;Meinert,2012